Valeo Pharma (CSE: VPH) to Report Third Quarter 2020 Results and Hold Investors Conference Call / Webcast
MONTREAL, Sept. 23, 2020 – Valeo Pharma Inc. (CSE: VPH) (FSE: VP2) (“Valeo” or the “Company“), a Canadian specialty pharmaceutical company, announced today that it will report its financial results and highlights for the third quarter ended July […]
